New investment helps to ensure patients can access high-quality and reproducible testing across labs worldwide NEW YORK, June 2, 2025 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) today announced an investment of up to $2M to expand a quality control program for blood...
Hence then, the article about the alzheimer s drug discovery foundation s diagnostics accelerator dxa invests in expansion of quality control program for blood and csf biomarkers was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( The Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator (DxA) Invests in Expansion of Quality Control Program for Blood and CSF Biomarkers )
Also on site :
- Iconic Revenge Song, Ranked Among ‘Best Breakup Songs of All Time,’ Was Originally Written for Gretchen Wilson
- Tom Cruise Says Taylor Swift Was ‘Schooling Me on Football’ at Chiefs Game, Calls Her a ‘Brilliant Musician and Director’
- ‘The game Buffalo deserved’: Bills Mafia and players share reaction to victory in first game at new stadium